As of Jan. 12, 2023, the federal government no longer requires health care professionals to process a DATA Waiver (X-Waiver) to prescribe buprenorphine and other drugs for treating opioid use disorder (OUD).
As a health care professional, if you have a current DEA registration with Schedule III authority, you may prescribe buprenorphine for treatment, if permissible by applicable state law, with no limits on the number of patients treated.
Professional organizations, such as the American Medical Association, recommend the use of medication-assisted treatment (MAT) and support removal of the X-Waiver. We encourage health care professionals with DEA-prescribing authority to proactively identify OUD in members and treat them using evidence-based treatment protocols and as permitted by your state licensing board.
The following resources can help you identify and treat members with OUD in your practice:
Contact your provider advocate for information on how we can support your practice.